Search Results 451-460 of 17463 for alopecia
Any unresolved toxicity NCI CTCAE Grade ≥2 from previous anticancer therapy with the exception of alopecia, vitiligo, and the laboratory values defined in the ...
... alopecia or laboratory abnormalities otherwise meeting eligibility requirements. 2. Participants with clear cell, mucinous, sarcomatous (including ...
... alopecia) or conditions requiring hormonal replacement therapies such as type 1 diabetes mellitus or hypothyroidism are permitted to enroll * Known ...
Exception to this criterion: participant with any grade of alopecia are allowed to enter in the study. Participant with Child Pugh score B or C. Participant ...
Patients with vitiligo or alopecia Patients with hypothyroidism (eg, following Hashimoto syndrome) stable on hormone replacement Any chronic skin ...
Toxicities due to prior therapy must be stable and recovered to Grade ≤ 1 (except for clinically nonsignificant toxicities such as alopecia). Age 18 or ...
Recovery to Grade 1 or baseline of any non-hematologic toxicities due to prior treatments, excluding alopecia and Grade 2 peripheral neuropathy. Exclusion ...
... alopecia and peripheral neuropathy. Have adequate organ function, including: Hematologic: absolute neutrophil count ≥1.5 × 10⁹/Liter (L), platelets ≥100 ...
... . VID-20177817. Home; YouTube-Pulmonary Tests PFT Chest CT Flexible Bronchoscopy. 3X your impact! Give Now! Your gift can go 3X as far to shape the ...
... alopecia, radiation tissue fibrosis, or peripheral neuropathy) * Known allergies, hypersensitivity, or intolerance to JNJ-69086420 or its excipients and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
There's still time to triple your impact.